CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 8.33
+1.43 (20.72%)
At close: Mar 27, 2026
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 12.27 billion as of March 27, 2026. Its market cap has increased by 169.11% in one year.
Market Cap
12.27B
Enterprise Value
11.58B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.33
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 12.27B, a decrease of -3.08%. That is a compound annual growth rate of -0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 12.27B | 58.07% |
| Dec 31, 2025 | 7.76B | 164.29% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 16.02B |
| Ascentage Pharma Group International | 15.74B |
| Nanjing Leads Biolabs | 13.39B |
| Everest Medicines | 12.25B |
| HBM Holdings | 9.95B |
| Lepu Biopharma | 9.29B |
| Guangzhou Innogen Pharmaceutical Group | 9.27B |
| Shanghai Haohai Biological Technology | 9.06B |